Phase 4 N=180 Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
Nausea · Vomiting · Satisfaction
Primary: Nausea — 44; 14; 22 Participants — p=< 0.00001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=49 Dexamethasone for Post-cesarean Delivery Pain
Pain, Postoperative · Postoperative Nausea and Vomiting
Primary: Morphine Consumption at 24 Hours Post-op — 15; 13.75 milligram — p=0.740
Phase 4 N=332 Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Pain
Primary: Patient Perception of Pain — 60; 68; 56; 63 mm
Phase 4 N=15 Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Pancreatic Cancer
Primary: To Determine the Sensitivity High Resolution Magnetic Resonance Imaging With Lymphotrophic Superparamagnetic Nanoparticles to Identify Small and Otherwise Undetectable…
Phase 4 N=25 Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds
Migraine
Primary: Pharmacokinetics Outcome (1 of 6) — 1411.96; 0.00; 649.78; 1123.88 ng/mL
Phase 4 N=515 PO vs. IV Acetaminophen Given Perioperatively for 24 hr Post-op Pain Control Following Total Hip or Knee Replacement
Post-op Pain
Primary: Total Post-operative Use of Opioids — 21.7; 21.7 Morphine milligram equivalents (MME)
Phase 4 N=113 Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
Acute Myelogenous Leukemia · Myelodysplastic Syndrome
Primary: Time to Failure — 16; 13 Days
Phase 4 N=540 Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Bladder Cancer · Cervical Cancer · Esophageal Cancer
Primary: Number of Participants With Salivary Cotinine-verified Smoking Abstinence at 6 Months — 36; 27 Participants — p=.23
Phase 4 N=21 Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression
Major Depressive Disorder
Primary: Remission of Depression — 10 Participants
Phase 4 N=29 Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis
Osteoarthritis
Primary: The Knee Osteoarthritis Outcome Score (KOOS) Pain Subscale — 63.1; 67.2 units on a scale
Phase 4 N=568 Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
Primary: Adjusted Mean Change From Baseline in HbA1c — -0.93; -0.96 percent
Phase 4 N=29 Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
Metastatic Renal Cell Carcinoma (mRCC)
Primary: Percentage of Progression-free Patients by Month 6 — 8.3; 46.2 Percentage of participants
Phase 4 N=28 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™
Herpes Zoster · Fibrosis
Primary: ELISPOT, Interferon-G Enzyme-Linked Immunospot Assay — 0; 0
Phase 4 N=128 Partnership for Rapid Elimination of Trachoma
Trachoma
Primary: Community Prevalence of Trachoma and Ocular C. Trachomatis (CT) Infection at Baseline — 30.7; 30.3; 31.1; 30.5 community
Phase 4 N=171 Attention Deficit Disorder Medication Response Study
ADHD - Inattentive Type · ADHD - Combined Type
Primary: Attention Deficit Hyperactivity Disorder Total Symptom Score — 21.4; 30.0; 20.2; 29.7 units on a scale — p=<0.05